Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.915
+0.025 (0.51%)
At close: Aug 13, 2025, 4:00 PM
4.910
-0.005 (-0.10%)
After-hours: Aug 13, 2025, 4:20 PM EDT
Organogenesis Holdings Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Organogenesis Holdings stock ranges from a low of $6.00 to a high of $9.00. The average analyst price target of $7.50 forecasts a 52.59% increase in the stock price over the next year.
Price Target: $7.50 (+52.59%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Organogenesis Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $7 → $9 | Buy | Maintains | $7 → $9 | +83.11% | Aug 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +42.42% | Jul 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $4 → $6 | Hold | Maintains | $4 → $6 | +22.08% | Mar 5, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +1.73% | Jun 28, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $5 | Buy | Reiterates | $5 | +1.73% | Mar 1, 2024 |
Financial Forecast
Revenue This Year
498.92M
from 482.04M
Increased by 3.50%
Revenue Next Year
541.77M
from 498.92M
Increased by 8.59%
EPS This Year
-0.03
from -0.01
EPS Next Year
0.20
from -0.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 523.9M | 566.8M | 595.8M |
| Avg | 498.9M | 541.8M | 578.8M |
| Low | 474.3M | 512.1M | 556.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 8.7% | 13.6% | 10.0% |
| Avg | 3.5% | 8.6% | 6.8% |
| Low | -1.6% | 2.6% | 2.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.03 | 0.23 | 0.34 |
| Avg | -0.03 | 0.20 | 0.33 |
| Low | -0.03 | 0.17 | 0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 68.9% |
| Avg | - | - | 64.1% |
| Low | - | - | 57.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.